Effect of Psychedelic (LSD and Psilocybin) Use in Treating Mental Disorders like Major Depressive Disorder (MDD)

Simple item page
dc.contributor.authorKahn, Zehra
dc.date.accessioned2022-05-16T18:06:00Z
dc.date.available2022-05-16T18:06:00Z
dc.date.issued2022-05
dc.description.abstractMajor Depressive Disorder (MDD) is a widespread problem throughout the United States with no shortage of treatments. Psilocybin, a serotonin agonist, is treatment for MDD that showed great potential but wasn’t explored much until recently. Psilocybin, when administered in micro doses along with therapy, showed great curative potential for MDD, ameliorating symptoms for long periods of time. Psilocybin has also shown to work quickly and was not addictive to the patients. This review looks at studies testing psilocybin as a treatment for MDD.
dc.identifier.urihttps://hdl.handle.net/1920/12870
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.subjectMajor depressive disorder
dc.subjectLSD
dc.subjectPsychedelics
dc.titleEffect of Psychedelic (LSD and Psilocybin) Use in Treating Mental Disorders like Major Depressive Disorder (MDD)
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
beng526_zk_update5_draft3.pdf
Size:
343.29 KB
Format:
Adobe Portable Document Format
Description:
the paper
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.52 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Volgenau School of Engineering Graduate Research